Balchem Q4 Adj. EPS $0.95 Beats $0.93 Estimate, Sales $228.70M Miss $234.66M Estimate
Portfolio Pulse from Benzinga Newsdesk
Balchem Corporation (NASDAQ:BCPC) reported Q4 adjusted EPS of $0.95, surpassing the $0.93 estimate, marking a 1.06% year-over-year increase. However, their Q4 sales of $228.70M fell short of the $234.66M estimate, a 1.65% decrease from the previous year.
February 16, 2024 | 12:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Balchem's Q4 earnings surpassed estimates with an adjusted EPS of $0.95, but sales missed expectations at $228.70M.
The mixed results with an earnings beat but a miss on sales could lead to neutral short-term stock price movement. Investors may weigh the positive earnings surprise against the slight sales disappointment, leading to uncertain short-term price direction.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100